Xcout Intel
Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for inflammatory and autoimmune diseases. Headquartered in California, the company advances a robust clinical pipeline and operates as a publicly traded enterprise.
Subscribe to see Ventyx Biosciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ventyx Biosciences, Inc. at a glance
Ventyx Biosciences, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $27M in September 2024. Xcout tracks 14 named people at Ventyx Biosciences, Inc., including Raju Mohan (Chief Executive Officer).
Ventyx Biosciences, Inc. leadership
- Raju MohanChief Executive Officer
- John NussExecutive Officer
- Mark S. FormanExecutive Officer
- Matthew MooreExecutive Officer
- Raju MohanExecutive Officer
- Allison HulmeDirector
8 more named people on record for Ventyx Biosciences, Inc., with roles, board committees and tenure — see the full roster →
Ventyx Biosciences, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $27M | — | |
| Series B | $51M | 1 named | |
| Series B | $51M | 12 named | |
| SEC Form D filing | $57.3M | — | |
| — | $114.3M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Ventyx Biosciences, Inc. news
Investors
Ventyx Biosciences, Inc. competitors
A few of Ventyx Biosciences, Inc.'s closest competitors — see the full list of competitors and alternatives →
Viela Bio, Inc. is a clinical-stage biotechnology company headquartered in Gaithersburg, Maryland, dedicated to the discovery, development, and commercialization of novel therapies for autoimmune and severe inflammatory diseases.
RAPT Therapeutics is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. Founded in 2015, the public company leverages its proprietary drug discovery platform to develop treatments for inflammatory and immunologic diseases.
Tr1X is a private, clinical-stage biotechnology company focused on developing regulatory T cell-based products for autoimmune and inflammatory diseases. The company aims to advance Tr1-based immunotherapies to address unmet medical needs and is headquartered in San Diego, California.
Inventisbio is a biopharmaceutical company that focuses on the discovery and development of innovative drugs for major diseases such as tumors, autoimmune diseases, and metabolic disorders. Utilizing an independent research and development platform, the company creates proprietary drug pipelines targeting oncology drivers, kinases, and autoimmune pathways to serve patients globally.
Expedition Therapeutics is a clinical-stage biotechnology company headquartered in San Francisco, California, developing novel oral small molecule therapies for serious inflammatory and respiratory diseases.
IpiNovyx Bio, Inc. is a biopharmaceutical company that discovers and develops targeted proteasome inhibitors to treat cancer, autoimmune, and inflammatory diseases. Utilizing a proprietary technology platform, the company focuses on advancing selective and reversible immunoproteasome inhibitors to create safer and more effective therapies for patients.
Get Ventyx Biosciences, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ventyx Biosciences, Inc. in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access